Fund Holdings — venBio Partners LLC

Total Portfolio Value:
$495.93M
Total Bought:
$84.39M
Total Sold:
$132.78M
Net Transaction:
-$48.39M
Notable People:
Venbio Partners, L.P.
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Parabilis Medicines Inc5,266,6975,266,6970$144.15M$170.06M34.29%+$25.91M
Pharvaris N V
COM
4,643,4304,458,977-184,453$160.57M$141.44M28.52%-$19.13M
Attovia Therapeutics Inc04,181,366+4,181,366$0$71.67M14.45%+$71.67M
Achieve Life Science Inc5,914,7205,914,7200$38.62M$47.85M9.65%+$9.23M
Alumis Inc4,528,4084,191,408-337,000$127.43M$30.97M6.25%-$96.45M
ALX Oncology Holdings Inc.(ALXO)12,884,63812,884,6380$26.67M$17.91M3.61%-$8.76M
Yarrow Bioscience Inc0554,769+554,769$0$12.49M2.52%+$12.49M
Lyell Immunopharma, Inc.(LYEL)337,697337,6970$4.74M$3.31M0.67%-$1.44M
Lisata Therapeutics, Inc.(LSTA)0156,460+156,460$0$225.3K0.05%+$225.3K
Harmony Biosciences Holdings, Inc.(HRMY)472,1940-472,194$17.19M$0—-$17.19M
Page 1 of 1
venBio Partners LLC — 13F Holdings — Q3 2026 | TickerTrail